CIK: 1806596 - Address: 2200 Pennsylvania Avenue Nw, Suite 300E, Washington, DC 20037
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
7/29/24 17:24
7/29/24
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsMoran Kevin PatrickDCOSVP,CFO,S-135.920-2-1229D
3/6/24 16:46
3/4/24
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsMoran Kevin PatrickDCOSVP,CFO,S.m-634.310-15-6232D
8/1/23 16:30
7/28/23
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsMoran Kevin PatrickDCOSVP,CFO,S-146.300-2-2121D
6/20/23 16:34
6/15/23
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsMoran Kevin PatrickDCOSVP,CFO,S-1016.290-16-11124D
3/6/23 18:25
3/2/23
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsMoran Kevin PatrickDCOSVP,CFO,S.m-876.270-14-9140D
12/7/22 17:56
12/6/22
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsMoran Kevin PatrickDCOSVP,CFO,M.d233.12087121D
12/7/22 17:56
12/6/22
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsMoran Kevin PatrickDCOSVP,CFO,S.d-5110.610-5-4121D
8/1/22 16:45
7/28/22
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsMoran Kevin PatrickDCOSVP,CFO,S-2510.970-2-2118D
3/2/22 21:27
3/1/22
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsMoran Kevin PatrickDCOSVP,CFO,S.dm-13911.260-12-9120D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact